Cefepime how supplied: Difference between revisions

Jump to navigation Jump to search
Abdurahman Khalil (talk | contribs)
No edit summary
Gerald Chi (talk | contribs)
mNo edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cefepime}}
{{Cefepime}}
{{CMG}};{{AE}}{{AK}}
{{CMG}}; {{AE}} {{AK}}





Latest revision as of 01:52, 6 January 2014

Cefepime
MAXIPIME® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Compatibility, Reconstitution, and Stability
Directions for Use
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]


MAXIPIME (cefepime hydrochloride, USP) for Injection is supplied as follows: MAXIPIME (cefepime hydrochloride, USP) for Injection in the dry state, is a white to pale yellow powder. Constituted solution of MAXIPIME can range in color from pale yellow to amber.

Storage

IN THE DRY STATE STORE AT 20 TO 25°C (68 TO 77°F) [SEE USP CONTROLLED ROOM TEMPERATURE.] PROTECT FROM LIGHT.